Literature DB >> 23516141

Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration.

Feng Mei1, S Y Christin Chong, Jonah R Chan.   

Abstract

The differentiation of and myelination by oligodendrocytes (OLs) are exquisitely regulated by a series of intrinsic and extrinsic mechanisms. As each OL can make differing numbers of myelin segments with variable lengths along similar axon tracts, myelination can be viewed as a graded process shaped by inhibitory/inductive cues during development. Myelination by OLs is a prime example of an adaptive process determined by the microenvironment and architecture of the central nervous system (CNS). in this review, we discuss how myelin formation by OLs may be controlled by the heterogeneous microenvironment of the CNS. Then we address recent findings demonstrating that neighboring OLs may compete for available axon space, and highlight our current understanding of myelin-based inhibitors of axonal regeneration that are potentially responsible for the reciprocal dialogue between OLs and determine the numbers and lengths of myelin internodes. Understanding the mechanisms that control the spatiotemporal regulation of myelinogenic potential during development may provide valuable insight into therapeutic strategies for promoting remyelination in an inhibitory microenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516141      PMCID: PMC5190510          DOI: 10.1007/s12264-013-1319-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  114 in total

1.  Ectopic myelinating oligodendrocytes in the dorsal spinal cord as a consequence of altered semaphorin 6D signaling inhibit synapse formation.

Authors:  Jennifer R Leslie; Fumiyasu Imai; Kaori Fukuhara; Noriko Takegahara; Tilat A Rizvi; Roland H Friedel; Fan Wang; Atsushi Kumanogoh; Yutaka Yoshida
Journal:  Development       Date:  2011-08-10       Impact factor: 6.868

2.  NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination.

Authors:  Xinhua Lee; Zhongshu Yang; Zhaohui Shao; Sheila S Rosenberg; Melissa Levesque; R Blake Pepinsky; Mengsheng Qiu; Robert H Miller; Jonah R Chan; Sha Mi
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

3.  Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system.

Authors:  Q R Lu; D Yuk; J A Alberta; Z Zhu; I Pawlitzky; J Chan; A P McMahon; C D Stiles; D H Rowitch
Journal:  Neuron       Date:  2000-02       Impact factor: 17.173

4.  NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

Authors:  A Chang; A Nishiyama; J Peterson; J Prineas; B D Trapp
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

5.  Maintenance of the relative proportion of oligodendrocytes to axons even in the absence of BAX and BAK.

Authors:  Kumi Kawai; Takayuki Itoh; Aki Itoh; Makoto Horiuchi; Kouji Wakayama; Peter Bannerman; James Y Garbern; David Pleasure; Tullia Lindsten
Journal:  Eur J Neurosci       Date:  2009-11-25       Impact factor: 3.386

6.  The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages.

Authors:  Hirohide Takebayashi; Yoko Nabeshima; Shosei Yoshida; Osamu Chisaka; Kazuhiro Ikenaka; Yo-ichi Nabeshima
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

7.  The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism.

Authors:  Fenghua Hu; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-01-30       Impact factor: 6.167

Review 8.  Mechanisms of axon ensheathment and myelin growth.

Authors:  Diane L Sherman; Peter J Brophy
Journal:  Nat Rev Neurosci       Date:  2005-09       Impact factor: 34.870

9.  Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

Authors:  Mark R Kotter; Wen-Wu Li; Chao Zhao; Robin J M Franklin
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

10.  Myosin II has distinct functions in PNS and CNS myelin sheath formation.

Authors:  Haibo Wang; Ambika Tewari; Steven Einheber; James L Salzer; Carmen V Melendez-Vasquez
Journal:  J Cell Biol       Date:  2008-09-15       Impact factor: 10.539

View more
  12 in total

1.  Myelin in development and disease.

Authors:  Mengsheng Qiu
Journal:  Neurosci Bull       Date:  2013-04       Impact factor: 5.203

Review 2.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

Review 3.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

4.  Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.

Authors:  Zhifang Li; Yangtao He; Shuangyi Fan; Binbin Sun
Journal:  Neurosci Bull       Date:  2015-08-06       Impact factor: 5.203

Review 5.  Axonal regeneration after spinal cord injury in zebrafish and mammals: differences, similarities, translation.

Authors:  Katarina Vajn; Jeffery A Plunkett; Alexis Tapanes-Castillo; Martin Oudega
Journal:  Neurosci Bull       Date:  2013-07-28       Impact factor: 5.203

Review 6.  Axon guidance factor netrin-1 and its receptors regulate angiogenesis after cerebral ischemia.

Authors:  Qiao Ding; Song-Jie Liao; Jian Yu
Journal:  Neurosci Bull       Date:  2014-05-30       Impact factor: 5.203

7.  Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43.

Authors:  Dongeun Heo; Jonathan P Ling; Gian C Molina-Castro; Abraham J Langseth; Ari Waisman; Klaus-Armin Nave; Wiebke Möbius; Phil C Wong; Dwight E Bergles
Journal:  Elife       Date:  2022-03-21       Impact factor: 8.713

Review 8.  Remyelination Therapy in Multiple Sclerosis.

Authors:  Danielle E Harlow; Justin M Honce; Augusto A Miravalle
Journal:  Front Neurol       Date:  2015-12-10       Impact factor: 4.003

Review 9.  Decorin treatment of spinal cord injury.

Authors:  Maryam Esmaeili; Martin Berry; Ann Logan; Zubair Ahmed
Journal:  Neural Regen Res       Date:  2014-09-15       Impact factor: 5.135

10.  G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.

Authors:  Hyun-Jeong Yang; Anna Vainshtein; Galia Maik-Rachline; Elior Peles
Journal:  Nat Commun       Date:  2016-03-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.